Evidence map›Paper›PMID 41568331›Full record

ArticleFrontiers in genetics2025

DDA-bench: a manually curated database for benchmarking datasets and baseline performance values in predicting drug-disease associations.

Han Xing, Yongjian Zhao

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Han XingSchool of Airspace Science and Engineering, Shandong University, Weihai, Shandong, China.
Yongjian ZhaoSchool of Airspace Science and Engineering, Shandong University, Weihai, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting drug-diseases associations provides hints in developing new drugs. Various computational methods have been developed. To develop better models for predicting drug-disease associations, two types of key resources must be obtained, the benchmarking dataset and the baseline performances. Collecting these resources usually requires extensive labors in reading literatures and extracting relevant information from the literature manually. We developed DDA-Bench databases services, which curates commonly used benchmarking datasets and up-to-date performance values from baseline studies. We analyzed data records in DDA-Bench database. We proposed that performance variations for a given method in the context of different reports should be noticed. The impact of dataset density on predictive performance exists, and should be considered in future studies. In addition, we release the DDA-Bench database to the public. The DDA-Bench database saves time and efforts in constructing data basis for developing new models for predicting drug-disease associations. The DDA-Bench database can be accessed at https://dda.csbios.net.

Indexed as

baseline performancebenchmarking datasetdrug-disease associationdrug repurposingperformance evaluation

Identifiers

PMID41568331
PMCPMC12818788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.